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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A284Purpose: The infrapatellar fat pad (IPFP) is commonly resected during
knee joint arthroplasty. This longitudinal study examined the associa-
tions between the maximum cross-sectional area (CSA) of the IPFP and
knee cartilage volume and pain in adults without knee osteoarthritis
(OA).
Methods: 297 adults without baseline knee pain or a diagnosis of knee
OA had MRI performed at baseline and follow-up (n ¼ 271). IPFP
maximal CSA and tibial cartilage volume were measured from MRI.
Body composition was performed at baseline using bio-impedance.
Knee pain was assessed at follow-up using the Western Ontario and
McMaster University Osteoarthritis Index (WOMAC).
Results: A larger IPFP at baselinewas associatedwith reduced knee pain
at follow-up (OR 0.5, 95% CI: 0.3 to 0.9, p ¼ 0.02) and lateral tibial
cartilage volume loss (b: -0.9% (95% CI: -1.6, -0.1%) per annum, p¼ 0.03).
The maximal CSA of the IPFP was predominantly located in the lateral
(54.2%), rather than the medial tibiofemoral compartment (1.7%). Male
gender (OR 12.0, 95% CI: 6.5 to 22.0, p < 0.001) and fat free mass (OR
1.15, 95% CI 1.04 to 1.28, p ¼ 0.007) were both associated with a large
IPFP.
Conclusions: A larger IPFP predicts reduced lateral tibial cartilage vol-
ume loss and knee pain and mechanistically might function as a local
shock-absorber. The lack of association between measures of adiposity
and the size of the IPFP might suggest that the IPFP size is not simply a
marker of systemic obesity.
OA: Cartilage and Bone
446
HIGH SYSTEMIC LDL CHOLESTEROL LEVELS DURING EXPERIMENTAL
OSTEOARTHRITIS LEAD TO INCREASED SYNOVIAL ACTIVATION AND
ECTOPIC BONE FORMATION AT END-STAGE OSTEOARTHRITIS,
WHILE EXCESSIVE LEVELS ACCELERATE DEVELOPMENT OF JOINT
PATHOLOGY ALREADY AT EARLY-STAGE OF OSTEOARTHRITIS
W. de Munter y, M.M. van den Bosch y, A.W. Sloetjes y,
P.M. van der Kraan y, T. Vogl z, J. Roth z, W.B. van den Berg y,
P.L. van Lent y. yRadboud Univ. Med. Ctr., Nijmegen, Netherlands; z Inst. of
Immunology, Muenster, Germany
Purpose: A relation between osteoarthritis (OA) and the metabolic
syndrome has long been established. One of the characteristics of the
metabolic syndrome is increased cholesterol levels. In a recent study, we
showed that LDL accumulationby LDL receptordeﬁcientmice resulted in
increased ectopic bone formation during experimental osteoarthritis.
In the present study we investigate OA pathology in ApoE deﬁcient
(ApoE-/-) mice with and without a cholesterol-rich diet, which is a
model for extremely high systemic LDL cholesterol levels.
Methods: Wild type (WT) and ApoE-/- mice received a normal or cho-
lesterol-rich diet for 54 days. At day 18, experimental OA was induced
by intra-articular injection of collagenase and animals were sacriﬁced at
day 28 and 54. Gene expression in synovium was measured by RT-PCR
and joint pathology was investigated by histology. LDL levels were
measured in serum and synovial wash-outs.
Results: ApoE-/- mice on a normal diet showed markedly higher LDL
levels than WT mice (8.90 mmol/L and 0.40 mmol/L, respectively;
p<0.001). While no differences between the two groups were found at
the early time point (day 28), end point OA (day 54) in ApoE-/- mice
showed a strong increase of ectopic bone formation, mainly at the
medial collateral ligament (fold increase 5.4; p<0.001) compared toWT
mice. No signiﬁcant differences in cartilage damage were found
between the two groups; a slight increase in synovial thickening,
however, was found in ApoE-/-mice (arbitrary score 1.9 versus 1.1 in WT
mice; p<0.05). Furthermore, synovial gene expression of both S100A8
and S100A9 (fold increase 1.8 and 1.4, respectively; p<0.05) and
S100A8/S100A9 protein levels of synovial wash-outs were increased in
ApoE-/- mice (fold increase 5.8; p<0.05), suggesting an activated status
of synovial lining cells.
In addition, we investigated whether a cholesterol-rich diet could
increase joint pathology after induction of OA. The diet increased LDL
levels even more in ApoE-/- mice (fold increase 2.1, compared to ApoE-/-
mice on a normal diet; p<0.001). In both ApoE-/- and WT mice on a
cholesterol-rich diet, excessive bone formationwas found in the medial
collateral ligament at day 54, however, no signiﬁcant difference was
found between the two groups. Interestingly, at the early time point
(day 28; 10 days after OA induction), histological differences between
the two groups were observed. Synovial thickening was four times
increased (p<0.001) in ApoE-/-mice on a cholesterol-rich diet and alsoectopic cartilage formation in the medial collateral ligament was
strongly increased (fold increase 2.7; p<0.01) compared to WT mice on
a cholesterol-rich diet.
Conclusions: LDL cholesterol accumulation by ApoE deﬁciency or a
cholesterol-rich diet results in increased synovial activation and ectopic
bone formation in experimental OA. Excessive LDL levels induced by a
combination of ApoE deﬁciency and a cholesterol-rich diet strongly
elevated synovial activation and ectopic bone formation at an early
stage of the disease without affecting cartilage destruction.
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EXPERIMENTAL EVALUATION OF DISCOIDIN DOMAIN RECEPTOR 2
AS AN IDEAL TARGET FOR DEVELOPMENT OF DISEASE-MODIFYING
OSTEOARTHRITIS DRUGS
L. Manning, L. Xu, Y. Li. Harvard Sch. of Dental Med. and Harvard Med.
Sch., Boston, MA, USA
Purpose: The goal of this study is to evaluate if the complete removal of
Ddr2 from the knee joint of mouse adult articular cartilage can delay
progression of osteoarthritis prior to or after initiation of articular car-
tilage degeneration. MMP-13, which has the ability to degrade both
aggrecans and type II collagen, would be an ideal target for disease-
modifying osteoarthritis drugs. However, the broad biological effects of
MMP-13 restrict its application as a target enzyme of inhibitor drugs in
the treatment of OA. Recent studies demonstrate that a speciﬁc amino
acid sequence, from amino acid 594 to 605, on type II collagen is pref-
erentially recognized by DDR2. The expression and subsequent activa-
tion of DDR2 were increased in human OA tissues and mouse models of
OA, and this was co-localized with elevated expression of MMP-13 in
degenerative articular cartilages. Conversely, reduced expression of Ddr2
in the heterozygous Ddr2 knockout condition attenuated progression of
articular cartilage degeneration in mouse models of OA. Typically, DDR2
is kept inactivated by the presence of the pericellular matrix, which
separates chondrocytes from type II collage in healthy articular cartilage.
Once enzymes, such as a serine proteinase, high temperature require-
ment A1, that are capable of degrading the pericellular molecules expose
chondrocytes to type II collagen, DDR2 is activated and then induces
expression of MMP-13 leading the degradation of type II collage and
proteoglycans resulting in joint destruction and OA.
Methods: 1) By use of conditional knock out techniques with aggrecan-
CreERt2 mice and ﬂoxed Ddr2 mice, Ddr2 was removed from articular
cartilage of knee joints in mice at 8 weeks of age via intraperitoneal
injection Tamoxifen injection (2mg/10g body weight) for 5 consecutive
days (Group A). Mice were subjected to destabilization of the medial
meniscus (DMM) or sham surgery at 10 weeks of age. 2) An additional
experimental group was subjected to DMM or sham surgery at 10
weeks of age and then Ddr2 was removed by intraperitoneal injection
Tamoxifen injection 8 weeks later (Group B). 3) Knee joints fromGroups
A and B mice and their corresponding controls (n¼7) were then col-
lected for morphological analysis. Knee joints from mice in Group A
were harvested at 8 weeks (n¼7) or 16 weeks (n¼9) post-surgery and
those from Group B (n¼5) at 16 weeks post-surgery. 4) Histology was
performed. 5) ORASI Modiﬁed Mankin Score was used to evaluate
articular cartilage degeneration. 6) Statistically signiﬁcant differences
were determined via T-test.
Results: 1) The average modiﬁed score for Group A 8 week control was
1.64 (score range 1.5-2) whereas the average modiﬁed score with Ddr2
removed was 0.64 (score range 0.5-1) [P<0.05]. 2) The averagemodiﬁed
score for Group A 16 week control was 4.67 (score range 4-5) and the
average modiﬁed score with Ddr2 removed was 1.27 (score range 0.5-3)
[P<0.05]. 3) The average modiﬁed score for Group Bwas 1.1 (score range
0.5-2).
Conclusions: Conditional removal of Ddr2 in articular cartilage atte-
nuated articular cartilage degeneration in mature knee joints of mouse
models of OA. Therefore, inhibiting activity of DDR2, may be considered
in treatment of OA in mature joints in humans.
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ASSOCIATION BETWEEN CARTILAGE DEGENERATION AND
SUBCHONDRAL BONE METABOLISM IN PATIENTS WITH KNEE
OSTEOARTHRITIS
M. Kretzschmar y,z, O. Maas z, G.B. Joseph y, D. Wild z. yUniv. of California
San Francisco, San Francisco, CA, USA; zUniv. Hosp. Basel, Basel,
Switzerland
Figure 2. Total volume of fabella as a function of surgery type. Bars rep-
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A285Purpose: The purpose of this retrospective cross-sectional study was to
investigate the association between cartilage lesions assessed with 3T
MRI and remodeling of the subchondral bone detected by 99mTc-DPD-
SPECT/CT.
Methods: 99mTc-DPD-SPECT/CT and MRI of 27 knees of 25 patients
with chronic knee pain and risk factors for osteoarthritis were evaluated
independently by one nuclear physician and one radiologist. Six regions
(patella, trochlea, medial/lateral tibia, medial/lateral femur) were vis-
ually assessed according to structural joint lesions graded with a
modiﬁed Whole Organ MR imaging score (WORMS) and according to
subchondral 99mTc-DPD-SPECT uptake visually graded with 0¼normal
uptake, 1¼moderately elevated uptake, 2¼severely elevated uptake.
Relationships between lesion scores and uptake were quantiﬁed using
two methods: 1. For the global assessment per joint, we used a linear
regression and Spearman correlations and 2. For the assessment of each
of 162 regions, general estimating equations was used to control for
multiple measurements per subject.
Results: Elevated subchondral uptake was signiﬁcantly associated with
the grade (p<0.0001) and with the depth of cartilage lesions
(p<0.0001). A similar association was observed between bone marrow
edema pattern (BMEP) lesions and cartilage lesions.
Conclusions: Both, functional and structural changes of the sub-
chondral bone in terms of scintigraphic osseous activity and the pres-
ence and degree of BMEP lesions were signiﬁcantly associated with
cartilage lesions in patients with osteoarthritis of the knee. This asso-
ciation was pronounced with full thickness lesions indicating a possible
protective effect of the cartilage layer for the subjacent bone.
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REDUCED EGF RECEPTOR SIGNALLING AGGRAVATES SIGNS OF POST-
TRAUMATIC OSTEOARTHRITIS IN THE CALCIFIED TISSUES OF THE
KNEE
S. Shin y, L. Milo y, E. Floreani y, A. Pozzi z, A. Clark y. yUniv. of Calgary,
Calgary, AB, Canada; zVanderbilt Univ., Nashville, TN, USA
Purpose: Post-traumatic osteoarthritis (PTOA) develops in 40% of
people following a signiﬁcant knee injury. In contrast to spontaneous
OA where diagnosis occurs with end stage disease when patients
present with pain, the time between injury and end stage PTOA offers a
critical opportunity to intervene in the disease process before debili-
tating signs or symptoms of OA are apparent.
Two key players in chondrocyte homeostasis are integrins and growth
factor receptors. The collagen receptor integrin a1b1 negatively regu-
lates epidermal growth factor receptor (EGFR) signalling and its
expression is increased in cartilage with spontaneous OA. Interestingly,
integrin a1-null mice develop spontaneous OA twomonths earlier than
wildtype controls. Furthermore, Mig-6-null mice show increased EGFR
signalling and accelerated spontaneous OA. The role of integrin a1b1 inFigure 1. Total volume of anterior medial meniscus as a function of time
post- surgery and genotype. 12E received erlotinib and 12 received
vehicular control by daily gavage. Bars represent 95% conﬁdence interval.
Signiﬁcantly (p<0.05) different from * ¼ all other points, # ¼ 2 and 12
week equivalent, þ ¼ 8 and 12 week equivalent.PTOA and the mechanism(s) by which this receptor exerts its inﬂuence
upon OA are unknown. We hypothesized that integrin a1b1 protects
against PTOA by a mechanism that involves reduced EGFR activation
and signalling.
Methods: All methods were approved by the University of Calgary
Animal Care Committee. Surgery to destabilize the medial meniscus
(DMM) or sham control surgery was performed on the left leg of 50
skeletally mature BALB/c male a1-null and wildtype mice. Mice were
sacriﬁced at 2, 4, 8 and 12 weeks post-surgery. An additional group of
mice received the EGFR inhibitor erlotinib (50mg/kg/day by gavage)
starting the day after surgery. At sacriﬁce, hind-limbs were isolated,
skinned and ﬁxed prior to microCT scanning. Bone mineral density and
volumewere calculated for the calciﬁed portions of the menisci, fabella,
medial collateral ligament, trabecular, and subchondral bone. Datawere
analyzed with ANOVA and Fisher LSD post hoc (p<0.05).
Results: There was no signiﬁcant difference in mass between wildtype
and integrin a1-null mice (31.7 ± 0.4g vs 31.1 ± 0.3g, respectively). As
expected, the anterior medial meniscus volume increased from 2 to 12
weeks only in the DMM surgery leg of both wildtype and a1-null mice
(Figure 1).
Mice in the erlotinib group had larger anterior medial meniscal volume
at 12 weeks post-surgery compared to control, and this difference was
greater inwildtype versus a1-null mice (Figure 1). Among the 150 joints
analyzed, 17 joints had a partially calciﬁed medial collateral ligament
(MCL). Interestingly, 7 (41%) of these joints belonged to the erlotinibresent a 95% conﬁdence interval. Signiﬁcantly (p<0.05) different from * ¼
all other points.
Figure 3. Apparent density of fabella as a function of surgery type. Bars
represent a 95% conﬁdence interval. Signiﬁcantly (p<0.05) different from
þ ¼ all other points except Sham equivalent.
